J&J Mulls Diagnostic Unit Sale, Expects Product Launches in 2013

Disappointing fourth quarter diagnostic sales and strong competition from companies like Abbott, Roche and Siemens have Johnson & Johnson eyeing a future without its $2.2 billion Ortho Clinical Diagnostics (OCD) business.
Devices & Diagnostics Letter